Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.29
-0.50 (-3.63%)
At close: Mar 6, 2026, 4:00 PM EST
13.31
+0.02 (0.15%)
After-hours: Mar 6, 2026, 7:00 PM EST
Avanos Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 701.2 | 687.8 | 673.3 | 684.1 | 587 | Upgrade
|
| Revenue Growth (YoY) | 1.95% | 2.15% | -1.58% | 16.54% | -17.88% | Upgrade
|
| Cost of Revenue | 347.3 | 306.5 | 293.6 | 289.9 | 287.8 | Upgrade
|
| Gross Profit | 353.9 | 381.3 | 379.7 | 394.2 | 299.2 | Upgrade
|
| Selling, General & Admin | 325.8 | 332.3 | 335 | 326.5 | 257.2 | Upgrade
|
| Research & Development | 11.6 | 12.4 | 27.2 | 29.2 | 30.6 | Upgrade
|
| Other Operating Expenses | 1 | 3.8 | 3.3 | 3 | 7.3 | Upgrade
|
| Operating Expenses | 338.4 | 348.5 | 365.5 | 358.7 | 295.1 | Upgrade
|
| Operating Income | 15.5 | 32.8 | 14.2 | 35.5 | 4.1 | Upgrade
|
| Interest Expense | -7.8 | -12.2 | -15 | -10 | -3.3 | Upgrade
|
| Interest & Investment Income | 3.2 | 5.1 | 2.9 | 1.2 | 0.2 | Upgrade
|
| EBT Excluding Unusual Items | 10.9 | 25.7 | 2.1 | 26.7 | 1 | Upgrade
|
| Merger & Restructuring Charges | -1.5 | 0.8 | - | - | -28.1 | Upgrade
|
| Impairment of Goodwill | -77 | -336.5 | - | - | - | Upgrade
|
| Asset Writedown | - | -100.2 | - | - | - | Upgrade
|
| Legal Settlements | 1.4 | - | -10 | - | -15 | Upgrade
|
| Other Unusual Items | - | 6.9 | - | - | - | Upgrade
|
| Pretax Income | -66.2 | -403.3 | -7.9 | 26.7 | -42.1 | Upgrade
|
| Income Tax Expense | 6.7 | -17 | 2 | 5.2 | -11.2 | Upgrade
|
| Earnings From Continuing Operations | -72.9 | -386.3 | -9.9 | 21.5 | -30.9 | Upgrade
|
| Earnings From Discontinued Operations | - | -5.8 | -51.9 | 29 | 37.2 | Upgrade
|
| Net Income | -72.9 | -392.1 | -61.8 | 50.5 | 6.3 | Upgrade
|
| Net Income to Common | -72.9 | -392.1 | -61.8 | 50.5 | 6.3 | Upgrade
|
| Net Income Growth | - | - | - | 701.59% | - | Upgrade
|
| Shares Outstanding (Basic) | 46 | 46 | 47 | 47 | 48 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 46 | 47 | 47 | 49 | Upgrade
|
| Shares Change (YoY) | 0.65% | -1.29% | -1.48% | -2.67% | 1.67% | Upgrade
|
| EPS (Basic) | -1.57 | -8.52 | -1.33 | 1.08 | 0.13 | Upgrade
|
| EPS (Diluted) | -1.57 | -8.53 | -1.33 | 1.08 | 0.13 | Upgrade
|
| EPS Growth | - | - | - | 722.10% | - | Upgrade
|
| Free Cash Flow | 43.1 | 82.9 | 14.6 | 71.6 | 66.3 | Upgrade
|
| Free Cash Flow Per Share | 0.93 | 1.80 | 0.31 | 1.51 | 1.36 | Upgrade
|
| Gross Margin | 50.47% | 55.44% | 56.39% | 57.62% | 50.97% | Upgrade
|
| Operating Margin | 2.21% | 4.77% | 2.11% | 5.19% | 0.70% | Upgrade
|
| Profit Margin | -10.40% | -57.01% | -9.18% | 7.38% | 1.07% | Upgrade
|
| Free Cash Flow Margin | 6.15% | 12.05% | 2.17% | 10.47% | 11.29% | Upgrade
|
| EBITDA | 54.4 | 78.3 | 57.7 | 76.7 | 42.4 | Upgrade
|
| EBITDA Margin | 7.76% | 11.38% | 8.57% | 11.21% | 7.22% | Upgrade
|
| D&A For EBITDA | 38.9 | 45.5 | 43.5 | 41.2 | 38.3 | Upgrade
|
| EBIT | 15.5 | 32.8 | 14.2 | 35.5 | 4.1 | Upgrade
|
| EBIT Margin | 2.21% | 4.77% | 2.11% | 5.19% | 0.70% | Upgrade
|
| Effective Tax Rate | - | - | - | 19.48% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.